+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gene Therapy"

Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Crohns Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Crohns Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 100 Pages
  • Global
From
Gene Therapies For Cardiomyopathies - Pipeline Insight, 2024 - Product Thumbnail Image

Gene Therapies For Cardiomyopathies - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chronic Idiopathic Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Idiopathic Urticaria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Psoriasis vulgaris - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis vulgaris - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Systemic Sclerosis - Pipeline Insight, 2024 - Product Thumbnail Image

Systemic Sclerosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Sjogren's syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Sjogren's syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Rosacea - Pipeline Insight, 2024 - Product Thumbnail Image

Rosacea - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Hereditary Angioedema - Pipeline Insight, 2024 - Product Thumbnail Image

Hereditary Angioedema - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 90 Pages
  • Global
From
Immunologic Deficiency Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Immunologic Deficiency Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2024 - Product Thumbnail Image

Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 75 Pages
  • Global
From
Uveitis - Pipeline Insight, 2024 - Product Thumbnail Image

Uveitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Androgenetic Alopecia - Pipeline Insight, 2024 - Product Thumbnail Image

Androgenetic Alopecia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Mucopolysaccharidosis III - Pipeline Insight, 2024 - Product Thumbnail Image

Mucopolysaccharidosis III - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Cutaneous Lupus Erythematosus - Pipeline Insight, 2024 - Product Thumbnail Image

Cutaneous Lupus Erythematosus - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Mastocytosis - Pipeline Insight, 2024 - Product Thumbnail Image

Mastocytosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Juvenile Rheumatoid Arthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Juvenile Rheumatoid Arthritis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Wiskott-Aldrich Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Wiskott-Aldrich Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Lymphedema - Pipeline Insight, 2024 - Product Thumbnail Image

Lymphedema - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Post-Operative Cataract Surgery Inflammation - Pipeline Insight, 2024 - Product Thumbnail Image

Post-Operative Cataract Surgery Inflammation - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

Gene therapy is a form of genomics that involves the introduction of genetic material into a patient's cells to treat or prevent a disease. It is a rapidly growing field of medicine, with the potential to revolutionize the treatment of genetic diseases. Gene therapy works by introducing a healthy gene into a patient's cells, replacing a defective gene or providing a missing gene. This can be done through a variety of methods, such as viral vectors, gene editing, and stem cell therapy. Gene therapy has the potential to provide long-term, curative treatments for a wide range of genetic diseases, including cancer, cystic fibrosis, and hemophilia. It is also being explored as a potential treatment for other conditions, such as Alzheimer's disease and Parkinson's disease. Gene therapy is a rapidly growing field, with many companies investing in research and development. Companies in the gene therapy market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Spark Therapeutics. Show Less Read more